#geneseeq

[pmi-report111]

GIST Mutation Detection Kit Market   2031; Region Wise Analysis of Top Players in   by its Types and Application

The global "GIST Mutation Detection Kit Market Market" report indicates a consistent and robust growth trend in recent times, projecting a positive trajectory expected to persist until 2031. A significant trend observed in the GIST Mutation Detection Kit Market market is the rising consumer inclination towards environmentally sustainable and eco-friendly products. Furthermore, a notable advancement in this market is the increasing incorporation of technology to elevate both product quality and efficiency. Cutting-edge technologies like artificial intelligence, machine learning, and block chain are actively employed to develop innovative products that outperform traditional options in terms of effectiveness and efficiency. The GIST Mutation Detection Kit Market Market Research Report for 2024 highlights emerging trends, growth opportunities, and potential scenarios envisioned up to the year 2031.

By delving into the latest trends, the report keeps businesses abreast of the dynamic market environment, helping them identify emerging opportunities and navigate potential challenges. The meticulous analysis covers various aspects, offering valuable insights into the historical performance of the market and presenting the current (CAGR) status.

Get a Sample Copy of the Report at: https://www.proficientmarketinsights.com/enquiry/request-sample-pdf/1838

Who are the biggest GIST Mutation Detection Kit Market manufacturers worldwide?

EntroGen (U.S.)

Bio-Rad (U.S.)

AmoyDx (China)

MCLAB (China)

Thermo Fisher Scientific (U.S.)

LCM Genect (Italy)

NimaGen (Netherlands)

Beyotime Biotechnology (China)

Genetron Health (China)

Jiangsu MicroDiag Biomedicine Technology (China)

HELIXGEN (Guangzhou) (China)

Geneseeq (Canada)

ASBACH MEDICAL PRODUCTS GMBH (AMP) (Germany)

Diogene (Swizerland)

3B BlackBio Biotech India (India)

Panagene (South Korea)

Medaysis (U.S.)

The GIST Mutation Detection Kit Market Market is described briefly as follows:

The global GIST Mutation Detection Kit Market Size was USD 409.4 million in 2024 and the market is projected to touch USD 574.2 million by 2031, exhibiting a CAGR of 5.80% during the forecast period.

SWOT Analysis of GIST Mutation Detection Kit Market Market:

A SWOT analysis involves evaluating the strengths, weaknesses, opportunities, and threats of a particular market or business. In the case of the keyword market, we'll be looking at the factors that can impact the industry's performance.

Pestle Analysis of GIST Mutation Detection Kit Market Market:

To better comprehend the market environment, a five-force analysis is performed, which takes into account the bargaining power of the customer, the supplier, the threat of substitutes, the threat of new entrants, and the threat of competition.

Get a Sample Copy of GIST Mutation Detection Kit Market Market Report

What are the Types in GIST Mutation Detection Kit Market Market?

PDGFRA

C-KIT

What are Applications in GIST Mutation Detection Kit Market Market?

Medical

Research

Others

Inquire or Share Your Questions If Any before the Purchasing This Report: https://www.proficientmarketinsights.com/enquiry/queries/1838

Geographical Segmentation:

Geographically, this report is segmented into several key regions, with sales, revenue, market share, and GIST Mutation Detection Kit Market market growth rate in these regions, from 2017 to 2028, covering

North America (United States, Canada and Mexico)

Europe (Germany, UK, France, Italy, Russia and Turkey etc.)

Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia, and Vietnam)

South America (Brazil etc.)

Middle East and Africa (Egypt and GCC Countries)

Some of the key questions answered in this report:

Who are the worldwide key Players of the GIST Mutation Detection Kit Market Industry?

How the opposition goes in what was in store connected with GIST Mutation Detection Kit Market?

Which is the most driving country in the GIST Mutation Detection Kit Market industry?

What are the GIST Mutation Detection Kit Market market valuable open doors and dangers looked by the manufactures in the worldwide GIST Mutation Detection Kit Market Industry?

Which application/end-client or item type might look for gradual development possibilities? What is the portion of the overall industry of each kind and application?

What centered approach and imperatives are holding the GIST Mutation Detection Kit Market market?

What are the various deals, promoting, and dissemination diverts in the worldwide business?

What are the key market patterns influencing the development of the GIST Mutation Detection Kit Market market?

Financial effect on the GIST Mutation Detection Kit Market business and improvement pattern of the GIST Mutation Detection Kit Market business?

Purchase this Report (Price 3200 USD for A Single-User License) at: https://www.proficientmarketinsights.com/purchase/1838

TOC of Global GIST Mutation Detection Kit Market Market Research Report 2023

1 GIST Mutation Detection Kit Market Market Overview

2 Market Competition by Manufacturers

3 GIST Mutation Detection Kit Market Production by Region

4 GIST Mutation Detection Kit Market Consumption by Region

5 Segment by Type

6 Segment by Application

7 Key Companies Profiled

8 Industry Chain and Sales Channels Analysis

9 GIST Mutation Detection Kit Market Market Dynamics

10 Research Finding and Conclusion

11 Methodology and Data Source

[researchvishal]

Cancer Diagnostics Market : Gross Margin, Cost, and Revenue Forecasts to 2032

The global cancer diagnostics market is projected to expand steadily at a CAGR 7.1% value, during the forecast period 2022-2032. In the year 2022, the market size is projected to expand and gain a global market valuation of US$ 191 Billion. Considering this increasing growth and demand in the global market, the cancer diagnostics market is expected to reach US$ 379 Billion by 2032.

Technological advancements in various fields such as biopsy, imaging, biomarkers and endoscopy, rising prevalence of cancer, increase in government initiatives for creating awareness, rapidly increase in geriatric population, and growing government funding are key factors driving the growth of the cancer diagnostics market.

Timely detection of cancer requires suitable diagnostic tests to screen the immunosuppressed population which is at moderate risk of cancer, particularly for lung cancer, cervical cancer, breast cancer, prostate cancer, colon cancer and melanoma. Growing awareness of early signs and symptoms of cancer among physicians and other healthcare professionals as well as among the general population supplements the growth ofcancer diagnostics.

Inclusion of cancer screening tests in National Cancer Screening Programs is another major factor expected to fuel the demand for cancer diagnostics. Introduction of regular mammography into national cancer programs by major developed countries where the incidence of breast cancer is high that is leading towards increasing adoption of cancer diagnostics in developed region.

For instance, the U.S. government has included the National Mammography Program in its national cancer screening programs. The government of Australia is taking initiative by conducting 3 cancer screening programs such as the National Cervical Screening Program, BreastScreen Australia and the National Bowel Cancer Screening Program. Similarly, most of the countries in Europe are continuously adopting HPV DNA screening for cervical cancer as a part of national cervical cancer programs.

Short-term Negative Impact Likely Due to COVID-19

The cancer diagnostics market is expected to experience short-term negative growth owing to a reduction in the cancer diagnosis procedures and adoption rate in developed and emerging countries. COVID-19 has impacted the landscape of cancer diagnostics. This has affected demand in various fronts, from prevention to screening and diagnosis, palliative care, treatment, and patient follow-up, to logistics and supplies of cancer diagnostic tests kits and other essential commodities.

Nonetheless after a period of muted growth, the market is poised to recover as economies return to normalcy. As per FMI, the rising incidence of lung cancer is attributable for over 19% of sales in the market.

Get Sample PDF Brochure: 

Key Takeaways from Cancer Diagnostics Market Study

The rising incidence of cancer will fuel the demand for cancer diagnostics, enabling the market register 8.5% CAGR between 2021 and 2022

Increasing cases of cancer in the U.S. accounts for 84% of demand in North America

Increasing healthcare spending will enable the U.K. market register over 5% y-o-y growth in 2021

Favorable reimbursement policies will support growth in France and Germany

Expansion of the healthcare sector will support growth in Japan and South Korea

“Advancements in cancer diagnostics and rising prevalence of cancer are expected to aid growth of cancer diagnostics. A majority of leading players in cancer diagnostic market are adopting strategic partnerships to sustain the increasing competitive pressure,” says the FMI Analyst

Who is Winning?

Partnerships between cancer diagnostic assay kits developers, instrument manufacturers and technology licensers are often intended to increase the consumer base.

For instance, in March 2021, Illumina, Inc. signed a partnership agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits by using Illumina’s NextSeq 550Dx sequencing platform for cancer.

In June 2020, Thermo Fisher Scientific signed an agreement with Daiichi Sankyo to Co-launch a companion diagnostic for patients with non-small cell lung cancer for identifying Her2 gene mutations using the Oncomine Dx target test.

Cancer Diagnostics Market by Category

Test Type

Tumour Biomarkers Tests

PSA Tests

CTC Tests

AFP Tests

CA Tests

HER2 Tests

BRCA Tests

ALK Tests

CEA Tests

EGFR Mutation Tests

KRAS Mutation Tests

Others

Imaging

Ultrasound

Mammography

MRI Scan

PET Scan

CT Scan

SPECT & Others

Biopsy

Needle Biopsy

Endoscopic Biopsy

Bone Marrow Biopsy

Others

Liquid Biopsy

Immunohistochemistry

In Situ Hybridization

Indication

Breast Cancer

Lung Cancer

Colorectal Cancer

Melanoma

Blood Cancer

Prostate Cancer

Ovarian Cancer

Stomach Cancer

Liver Cancer

Others

End-user

Hospital Associated Labs

Independent Diagnostic Laboratories

Diagnostic Imaging Centers

Cancer Research Institutes

Others

[leftcomputerpost]

Cancer Diagnostics Market is expected to reach US$ 203 billion in valuation by 2023

Rising prevalence of cancer is likely to fuel the demand for cancer diagnostics. A study by Future Market Insights (FMI) projects the cancer diagnostics market to surpass US$ 47.62 Bn in 2021. According to the World Health Organization (WHO), cancer is the second -leading cause of death globally, accounting for over 9.9 million deaths in 2020. Rising cases of cancer have been fuelling the demand for advanced diagnostics.

Technological advancements in various fields such as biopsy, imaging, biomarkers and endoscopy, rising prevalence of cancer, increase in government initiatives for creating awareness, rapidly increase in geriatric population, and growing government funding are key factors driving the growth of the cancer diagnostics market.

Timely detection of cancer requires suitable diagnostic tests to screen the immunosuppressed population which is at moderate risk of cancer, particularly for lung cancer, cervical cancer, breast cancer, prostate cancer, colon cancer and melanoma. Growing awareness of early signs and symptoms of cancer among physicians and other healthcare professionals as well as among the general population supplements the growth of cancer diagnostics.

Inclusion of cancer screening tests in National Cancer Screening Programs is another major factor expected to fuel the demand for cancer diagnostics. Introduction of regular mammography into national cancer programs by major developed countries where the incidence of breast cancer is high that is leading towards increasing adoption of cancer diagnostics in developed region.

For instance, the U.S. government has included the National Mammography Program in its national cancer screening programs. The government of Australia is taking initiative by conducting 3 cancer screening programs such as the National Cervical Screening Program, BreastScreen Australia and the National Bowel Cancer Screening Program. Similarly, most of the countries in Europe are continuously adopting HPV DNA screening for cervical cancer as a part of national cervical cancer programs.

Short-term Negative Impact Likely Due to COVID-19

The cancer diagnostics market is expected to experience short-term negative growth owing to a reduction in the cancer diagnosis procedures and adoption rate in developed and emerging countries. COVID-19 has impacted the landscape of cancer diagnostics. This has affected demand in various fronts, from prevention to screening and diagnosis, palliative care, treatment, and patient follow-up, to logistics and supplies of cancer diagnostic tests kits and other essential commodities.

Nonetheless after a period of muted growth, the market is poised to recover as economies return to normalcy. As per FMI, the rising incidence of lung cancer is attributable for over 19% of sales in the market.

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1090

Key Takeaways from Cancer Diagnostics Market Study

The rising incidence of cancer will fuel the demand for cancer diagnostics, enabling the market register 8.5% CAGR between 2021 and 2022

Increasing cases of cancer in the U.S. accounts for 84% of demand in North America

Increasing healthcare spending will enable the U.K. market register over 5% y-o-y growth in 2021

Favorable reimbursement policies will support growth in France and Germany

Expansion of the healthcare sector will support growth in Japan and South Korea

Who is Winning?

Partnerships between cancer diagnostic assay kits developers, instrument manufacturers and technology licensers are often intended to increase the consumer base.

For instance, in March 2021, Illumina, Inc. signed a partnership agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits by using Illumina’s NextSeq 550Dx sequencing platform for cancer.

In June 2020, Thermo Fisher Scientific signed an agreement with Daiichi Sankyo to Co-launch a companion diagnostic for patients with non-small cell lung cancer for identifying Her2 gene mutations using the Oncomine Dx target test.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global cancer diagnostics market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the cancer diagnostics market on basis of the main test type in detail, cover every aspect of the market such as Tumor Biomarkers Tests (PSA Tests, CTC Tests, AFP Tests, CA Tests, HER2 Tests, BRCA Tests, ALK Tests, CEA Tests, EGFR Mutation Tests, KRAS Mutation Tests, Others), Imaging (Ultrasound, Mammography, MRI Scan, PET Scan, CT Scan, SPECT & Others), Biopsy (Needle Biopsy, Endoscopic Biopsy, Bone Marrow Biopsy, Others), Liquid Biopsy, Immunohistochemistry and In Situ Hybridization, indication (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Blood Cancer, Prostate Cancer, Ovarian Cancer, Stomach Cancer, Liver Cancer and Others), and End-user (Hospital Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes and Others) across seven major regions.

For any queries linked with the report, ask an analyst >> https://www.futuremarketinsights.com/ask-question/rep-gb-1090

About FMI: Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us: Mr. Debashish Roy Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A, Jumeirah Lakes Towers, Dubai, United Arab Emirates MARKET ACCESS DMCC Initiative For Sales Enquiries: sales@futuremarketinsights.com For Media Enquiries: press@futuremarketinsights.com Website: https://www.futuremarketinsights.com

[amyzoho93blog-blog]

DNA Sequencing Chinese Market Overview - IngeniousReports

The Chinese sequencing industry experienced significant changes as the market grew in recent years. When the industry started in China before 2010, demand from government-sponsored R&D projects was its main driving force. The NIPT service, however, was interrupted by the government in early 2014. In mid-2014, the government only approved a few companies for providing NIPT to the Chinese market.

 Major key players are: Guangdong, Anchordx, Burning Rock, Daan Gene, Darui Biotechnology Co. Ltd., Ezlife, Forever Gen, Gene Denovo, IGE and many more.

 Download Free Sample: http://www.ingeniousreports.com/The-Chinese-Market-for-DNA-Sequencing

 Table of Contents:

 Chapter 1 Introduction

Study Goals and Objectives

Reasons for Doing This Study

Scope of Report

Intended Audience

Information Sources

Methodology

Regional Breakdown

Analysts' Credentials

Related BCC Research Reports

 Chapter 2 Summary and Highlights

Market Highlights

Largest Markets

Fastest-growing Markets

Regulations and Targets

Precision Medicine

End of One-Child Policy

End of NIPT Limitation

 Chapter 3 Chinese Sequencing Market

Overview

Industry Details

Brief History

Regions and Provinces

Driving Forces

Investment

Pre- and Post-sequencing Products

Sequencing Sample Prep Market by Application

Sequencing Informatics by Software Function

Sequencing Instruments and Consumables

Sequencing Instrument and Consumable Market by Product Type

Sequencing Instruments and Consumables by Platform

Sequencing Instruments and Consumables by Instrument Class

Sequencing Market

Clinical Application

Research and Development Application

Applied Application

Clinical Sequencing Service Market

Sequencing Service Market by Genome Type

 Chapter 4 Guangdong Sequencing Market

Overview

Industry Details

Driving Forces

Pre- and Post-Sequencing Products

Sequencing Sample Prep Market by Application

Sequencing Informatics by Software Function

Sequencing Instruments and Consumables

Sequencing Instrument and Consumable Market by Product Type

Sequencing Instruments and Consumables by Platform

Sequencing Instruments and Consumables by Instrument Class

Sequencing Market

Clinical Sequencing Service Market

Applied Sequencing Market

 Chapter 5 Beijing Sequencing Market

Overview

Industry Details

Driving Forces

Pre- and Post-Sequencing Products

Sequencing Sample Prep Market by Application

Sequencing Informatics by Software Function

Sequencing Instruments and Consumables

Sequencing Instruments and Consumables Market by Product Type

Sequencing Instruments and Consumables by Platform

Sequencing Instruments and Consumables by Instrument Class

Sequencing Service Market

Clinical Sequencing Service Market

Applied Sequencing Market

 Chapter 6 Shanghai Sequencing Market

Overview

Industry Details

Driving Forces

Pre- and Post-Sequencing Products

Sequencing Sample Prep Market by Application

Sequencing Informatics by Software Function

Sequencing Instruments and Consumables

Sequencing Instrument and Consumable Market by Product Type

Sequencing Instruments and Consumables by Platform

Sequencing Instruments and Consumables by Instrument Class

Sequencing Service Market

Chinese Clinical Sequencing Market

Applied Sequencing Service Market

 Chapter 7 Sequencing Market in Other Regions

Overview

Industry Details

Driving Forces

Pre- and Post-Sequencing Products

Sequencing Sample Prep Market by Application

Sequencing Informatics by Software Function

Sequencing Instruments and Consumables

Sequencing Instrument and Consumable Market by Product Type

Sequencing Instruments and Consumables by Platform

Sequencing Instruments and Consumables by Instrument Class

Sequencing Service Market

Clinical Sequencing Service Market

Applied Sequencing Market

 Chapter 8 Industry Structure and Market Strategies

Industry Structure

BGI Model

Main Characteristics

Disadvantages

Strategies

Market Channels

Instruments and Consumables

Sequencing

Bioinformatics

 Chapter 9 Company Profiles

Guangdong

ANCHORDX

BURNING ROCK

DAAN GENE

DARUI BIOTECHNOLOGY CO. LTD.

EZLIFE

FOREVER GEN

GENE DENOVO

IGE

KINGMED DIAGNOSTICS CENTER CO. LTD.

LINKED BIOTECH

MAGIGEN

RIBOBIO

TOP GENE

Shenzhen

BGI

DIRECT GENOMICS

HAPLOX

HYK GENE TECHNOLOGY CO. LTD.

IMUNO BIOTECH CO. LTD.

MACROGEN

MICROBIOTA

TGS

YUCEBIO CO. LTD.

CAPITALGENOMICS CO. LTD.

Beijing

ALLWEGENE

ANNOROAD GENE TECHNOLOGY

BERRY GENOMICS CO. LTD.

BIOLOGICAL COMPANY DIVISION, BEIJING COMPUTING CENTER

BIOMARKER

BOHENG

CAPITALBIO TECHNOLOGY

CYGNUS

EMEI TONGDE

GENECAST

GENEDOCK

GENEKANG

GENETRON

GENNLIFE

HIKEWELL

HKGI

HONOR TECH

HUANIU BIOTECHNOLOGY

HUASHENG HENGYE

HUAYIGENOMICS

IGENETECH

IMH BIO

IPE

JABREHOO

LUCIDUS

MICROHELIX GENE

MICROREAD

MYGENOSTICS

NOVOGENE BIOINFORMATICS TECHNOLOGY CO. LTD.

ORIGENE CHINA

QUANTI HEALTH

QY NODE

READER BIOINFORMATICS

SANVALLEY

SCISOON

SINOGENOMAX

SINOMDGENE

SINOPATH

SOLOMEN BROTHERS

VISHUOS

YIKON GENOMICS CO. LTD.

Shanghai

3D MEDICINES CORPORATION

ACCURAGEN INC.

ADICON CLINICAL LABORATORIES

BASETRA SHANGHAI

BENEGENE

BIOGENIUS

BIOON

BIOREFER

BIOTECAN

BIOTECHNOLOGY SHANGHAI

BIOTREE

CLOUDHEALTH MEDICAL GROUP LTD.

FIND BIO-TECH

GEMPLE

GENERGY SHANGHAI

GMINIX

HANYU

JIAYIN

KANGCHEN BIO-TECH

LOGIC INFORMATICS CO. LTD.

MAJORBIO

NOVELBIO

OEBIOTECH

OFFO

PAIHANG

QUANMAI

REALGENE

SANGON BIOTECH

SENSICHIP

SHANGHAI BIOASIA GENE CO. LTD.

SHANGHAI PERSONAL BIOTECHNOLOGY CO. LTD.

SHANGHAI YUNYING MEDICAL TECHNOLOGY CO. LTD.

SOUTH GENE

TINYGENE

TRI-I

UNIMED DIAGNOSTIC TECHNOLOGY LTD.

WUXI APPTEC

XINPEIJING

XYBIOTECH

YINGBIO

ZI BIO TECH

Zhejiang

ADICON CLINICAL LABORATORIES, INC.

BIOSAN

DIAN DIAGNOSTICS

HANGZHOU G-BIO BIOTECH CO. LTD.

HANGZHOU HEYI GENE TECHNOLOGY CO. LTD.

HANGZHOU LIANCHUAN BIO TECHNOLOGIES CO. LTD.

HANGZHOU MITIAN GENE TECHNOLOGY CO. LTD.

HANGZHOU PTM BIOLABS CO. INC.

HANGZHOU RUICHUANG BIOTECHNOLOGY CO. LTD.

HANGZHOU SHENGTING BIOTECH CO. LTD.

NEW HORIZON HEALTH

ZHEJIANG TIANKE HI-TECHNOLOGY DEVELOPMENT CO. LTD.

Jiangsu

BASECARE

BIONOVOGENE

CYAGEN

GENESEEQ

GENESKY

GENEWIZ

SUPERBIO

SUZSHOU BIOMEDICAL RESEARCH AND DEVELOPMENT CENTERS

Hubei

ABLIFE INC.

BENAGEN

FRASERGEN

GENEOCEAN

KINDSTAR

NEXTOMICS

Other Provinces

23MOFANG

RHONIN

ZIXIN PHARMACEUTICAL INDUSTRIAL CO. LTD.

 Chapter 10 Appendix: Glossary

 List of Tables:

Summary Table : Chinese Sequencing Market, by Product Type, Through 2022

Table 1 : Chinese Sequencing Market, by Major Segment, Through 2022

Table 2 : Chinese Sequencing Market, by Province, Through 2022

Table 3 : Sequencing Companies in China, by Region, Through December 2017

Table 4 : Chinese Pre- and Post-Sequencing Product Market, by Major Type, Through 2022

Table 5 : Chinese Sequencing Sample Prep Market, by Application, Through 2022

Table 6 : Chinese Sequencing Informatics Market, by Function, Through 2022

Table 7 : Next-Generation Sequencers in China, by Region, 2017

Table 8 : Chinese Sequencing Instrument and Consumable Market, by Product Type, Through 2022

Table 9 : Chinese Next-Generation Sequencing Instrument Companies, 2017

Table 10 : Comparison of BGISeq 500 and NextSeq 500, 2017

Table 11 : Chinese Sequencing Instrument Market, by Platform, Through 2022

Table 12 : Chinese Sequencing Instrument and Consumable Market, by Instrument Class, Through 2022

Table 13 : Chinese Sequencing Market, by End Use, Through 2022

Table 14 : Chinese Clinical Diagnosis Cases, by Region or Province, 2017

Table 15 : Chinese Clinical Sequencing Service Market, by Indication, Through 2022

Table 16 : Chinese Clinical Cancer Market, by Indication, Through 2022

Table 17 : Chinese Cancer Cases, by Indication, 2016

Table 18 : Chinese Cancer Cases, by Region, 2016

Table 19 : Chinese Clinical Next-Generation Sequencing Cancer Test Market, by Test Purpose, Through 2022

Table 20 : Chinese Clinical Cancer Market, by Test Complexity, Through 2022

Table 21 : Chinese Clinical Reproductive Health Market, by Application, Through 2022

Table 22 : Chinese Births, by Region, 2016

Table 23 : Chinese Next-Generation Sequencing NIPT Industry, 2017

Table 24 : Chinese NIPT Market, by Risk Type, Through 2022

Table 25 : Chinese Centers, by Region, April 2017

Table 26 : Chinese Reproductive Health Sequencing Market, by Test Complexity, Through 2022

Table 27 : Chinese Transplant Market, by Analysis Purpose, Through 2022

Table 28 : Chinese Transplant Cases, by Organ Type, 2015 and 2016

Table 29 : Chinese Sequencing Market for Transplant Monitoring, by Organ Type, Through 2022

Table 30 : Chinese Sequencing Service Market, by Test Complexity, Through 2022

Table 31 : Chinese Clinical Sequencing Market, by Test Purpose, Through 2022

Table 32 : Chinese Applied Sequencing Market, by Application, Through 2022

Table 33 : Chinese Sequencing Market, by Genome Type, Through 2022

Table 34 : Guangdong DNA Sequencing Market, by Major Segment, Through 2022

Table 35 : Guangdong Sequencing Market, by City, Through 2022

Table 36 : Guangdong Pre- and Post-Sequencing Product Market, by Major Type, Through 2022

Table 37 : Guangdong Sequencing Sample Prep Market, by Application, Through 2022

Table 38 : Guangdong Sequencing Informatics Market, by Software Function, Through 2022

Table 39 : Guangdong Sequencing Instrument and Consumable Market, by Product Type, Through 2022

Table 40 : Guangdong Sequencing Instrument Market, by Platform, Through 2022

Table 41 : Guangdong Sequencing Instrument and Consumable Market, by Instrument Class, Through 2022

Table 42 : Guangdong Sequencing Service Market, by End Use, Through 2022

Table 43 : Guangdong Clinical Sequencing Service Market, by Indication, Through 2022

Table 44 : Guangdong Clinical Cancer Sequencing Market, by Indication, Through 2022

Table 45 : Guangdong Cancer Liquid Biopsy Sequencing Companies, by 2017

Table 46 : Guangdong Reproductive Health Market, by Indication, Through 2022

Table 47 : Guangdong NIPT Sequencing Service Market, by Risk Type, Through 2022

Table 48 : Guangdong Applied Sequencing Service Market, by Application, Through 2022

Table 49 : Beijing Sequencing Market, by Major Segment, Through 2022

Table 50 : Beijing Pre- and Post-Sequencing Product Market, by Major Type, Through 2022

Table 51 : Beijing Sequencing Sample Prep Market, by Application, Through 2022

Table 52 : Beijing Sequencing Informatics Market, by Software Function, Through 2022

Table 53 : Beijing Sequencing Instrument and Consumable Market, by Product Type, Through 2022

Table 54 : Beijing Sequencing Instrument Market, by Platform, Through 2022

Table 55 : Beijing Sequencing Instrument and Consumable Market, by Instrument Class, Through 2022

Table 56 : Beijing Sequencing Service Market, by End Use, Through 2022

Table 57 : Beijing Clinical Sequencing Service Market, by Indication, Through 2022

Table 58 : Beijing Clinical Cancer Sequencing Market, by Indication, Through 2022

Table 59 : Beijing Cancer Liquid Biopsy Sequencing Companies, 2017

Table 60 : Beijing Reproductive Health Market, by Application, Through 2022

Table 61 : Beijing NIPT Market, by Risk Type, Through 2022

Table 62 : Beijing Applied Sequencing Service Market, by Application, Through 2022

Table 63 : Shanghai Sequencing Market, by Major Segment, Through 2022

Table 64 : Shanghai Pre- and Post-Sequencing Product Market, by Major Type, Through 2022

Table 65 : Shanghai Sequencing Sample Prep Market, by Application, Through 2022

Table 66 : Shanghai Sequencing Informatics Market, by Software Function, Through 2022

Table 67 : Shanghai Sequencing Instrument and Consumable Market, by Product Type, Through 2022

Table 68 : Shanghai Sequencing Instrument Market, By Platform, Through 2022

Table 69 : Shanghai Sequencing Instrument and Consumable Market, by Instrument Class, Through 2022

Table 70 : Shanghai Sequencing Service Market, by End Use, Through 2022

Table 71 : Shanghai Clinical Sequencing Service Market, by Indication, Through 2022

Table 72 : Shanghai Clinical Cancer Sequencing Market, by Indication, Through 2022

Table 73 : Shanghai Cancer Liquid Biopsy Sequencing Companies, 2017

Table 74 : Shanghai Reproductive Health Market, by Application, Through 2022

Table 75 : Shanghai NIPT Market, by Risk Type, Through 2022

Table 76 : Shanghai Applied Sequencing Service Market, by Application, Through 2022

Table 77 : Sequencing Market in Other Chinese Regions, by Major Segment, Through 2022

Table 78 : Pre- and Post-Sequencing Product Market in Other Regions, by Major Type, Through 2022

Table 79 : Sequencing Sample Prep Market in Other Regions, by Application, Through 2022

Table 80 : Other Regions Sequencing Informatics Market, by Software Function, Through 2022

Table 81 : Other Regions Sequencing Instrument and Consumable Market, by Product Type, Through 2022

Table 82 : Other Regions Sequencing Instrument Market, by Platform, Through 2022

Table 83 : Other Regions Sequencing Instrument and Consumable Market, by Instrument Class, Through 2022

Table 84 : Other Regions Sequencing Service Market, by End Use, Through 2022

Table 85 : Clinical Sequencing Service Market in Other Regions, by Indication, Through 2022

Table 86 : Other Regions Clinical Cancer Market, by Indication, Through 2022

Table 87 : Cancer Liquid Biopsy Sequencing Companies in Other Regions, 2017

Table 88 : Reproductive Health Market in Other Regions, by Application, Through 2022

Table 89 : Other Regions NIPT Market, by Risk Type, Through 2022

Table 90 : Other Regions Applied Sequencing Market, by Application, Through 2022

 List of Figures:

Summary Figure : Chinese Sequencing Market, by Product Type, 2016-2022

Figure 1 : Chinese Sequencing Market, by Major Segment, 2016-2022

Figure 2 : Chinese Sequencing Market, by Province, 2016-2022

Figure 3 : Leading Chinese Provinces for Sequencing Business, 2017

Figure 4 : Guangdong DNA Sequencing Market, by Major Segment, 2016-2022

Figure 5 : Beijing Sequencing Market, by Major Segment, 2016-2022

Figure 6 : Shanghai Sequencing Market, by Major Segment, 2016-2022

Figure 7 : Sequencing Market in Other Chinese Regions, by Major Segment, 2016-2022

About IngeniousReports:

IngeniousReports provides you the one-stop solution platform for all your technology and market research pain areas. We partner with leading publishers of market intelligence reports worldwide. We provide market research reports to all the industries, individuals and organizations with an objective of assisting them in taking the strategic business decision and grow their revenues.

Contact us at:

+1 347 480 2054

sales@ingeniousreports.com